SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (1411)10/14/1998 5:16:00 PM
From: Zvi Steinberg  Read Replies (1) | Respond to of 1491
 
Rick, you're right. I noticed the date after posting. However the site may provide the answer nevertheless as it hosts both CNS and AANS.
Best regards,
Zvi



To: Rick Strange who wrote (1411)10/15/1998 12:02:00 AM
From: Ariella  Read Replies (2) | Respond to of 1491
 
PARS said at the annual meeting that it was doing research on a pill form of HU-211, a different delivery vehicle. I came across an old BBC article on the NIMH research done on cannabis for stroke treatment. It says scientists hope for a delivery system similar to the inhalers used by asthma sufferers.

Any doctors have anything to say about the theoretical difference between pill form and inhaler form for HU-211?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News